Primary record
Propanamide, N-(13-(acetyloxy)-7-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)-2-oxo-, (1S-(1R*,2S*,3E,5E,7R*,9E,11E,13R*,15S*,19S*))-
- 库存
- 9,854 克
- 纯度
- 99.7 %
- CAS
- 23477-98-7
化合物标识与属性
- CAS
- 23477-98-7
- PubChem CID
- 5382567
- SMILES
- CC1C2CC(/C=C/C(=C/CC(/C=C/C(=C/C(C(C1=O)(C(=O)O2)C)NC(=O)C(=O)C)/C)O)/C)OC(=O)C
- Canonical SMILES
- CC(=O)OC1/C=C/C(C)=C/CC(O)/C=C/C(C)=C/C(NC(=O)C(C)=O)C2(C)C(=O)OC(C1)C(C)C2=O
名称与同义词
- Sedecamycin
- Lankacidin A
- Bundlin B
- Takelan
- Sedecamycine [French]
- Sedecamycinum [Latin]
- Sedecamicina [Spanish]
- Antibiotic T-2636A
- AC1NTJR7
- Antibiotic T-2636 A
- Lankacidin C 14-acetate
- Sedecamycin [USAN:INN]
- C27H35NO8
- LSNBAGMWJRMBEO-KDXLHJRLSA-N
- Antibiotic T-2636 C 14-acetate
- NSC145117
- CID5382567
- NSC 145117
- NSC-145117
- T 2636A
- T-2636A
- Ro 23-0731/000
- LS-139768
- 23477-98-7
- [(3E,5E,9E,11E)-7-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-2-(2-oxopropanoylamino)-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-13-yl] acetate
- (-)-N-((1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-Dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)pyruvamide 13-acetate
- [(4E,6E,10E,12E)-9-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-3-yl] acetate
- Propanamide, N-(13-(acetyloxy)-7-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)-2-oxo-, (1S-(1R*,2S*,3E,5E,7R*,9E,11E,13R*,15S*,19S*))-
- Propanamide,4,10,19- tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca- 3,5,9,11-tetraen-2-yl]-2-oxo-, (1S-(1R*,2S*,3E,5E,7R*,9E, 11E,13R*,15S*,19S*))-
- Pyruvamide, N-(7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)-, 13-acetate, (all-E)-(1S,2R,7S,13S,15R,19R)-(-)-